Pharmaceutical giant Pfizer to set up new hub at Swansea University – Wales Online, arch

Pharmaceutical giant Pfizer to set up new hub at Swansea University

Pfizer follows Fujitsu and the Bevan Commission to Swansea University’s Bay Campus

  • Share
  • Comments
  • 08:00, 14 MAR 2017
  • Share
  • Comments

PHARMACEUTICAL giant Pfizer is to join forces with Swansea University in a bid to improve healthcare in the region.

The company, which has around 2,500 UK staff, plans to set up an innovation hub at the Bay Campus and also work with Institute of Life Science (ILS) academics at the Singleton Campus medical school.

It follows similar Bay Campus announcements by IT firm Fujitsu and expert health group the Bevan Commission, which relocated to the Fabian Way site from Cardiff.

Read More

The Pfizer hook-up was announced by the company’s UK managing director Eric Nordkamp at a conference in the Welsh capital, but no figures on how many jobs could be created are currently available.

Mr Nordkamp said collaboration between the pharmaceutical sector, academia and the NHS was essential to tackle today’s health demands.

He said: “Through sharing our different skills and expertise we really can make a difference to improving health outcomes for patients, developing new ways of supporting the provision of healthcare.”

Arch pharma

Professor Richard Davies, vice-chancellor of Swansea University , welcomed the partnership, and added: “This exciting new collaboration with Pfizer, one of the world’s largest research-based biopharmaceutical companies, is part of an intensified mission of mobilising the university’s resources in support of the NHS Wales, working closely with health boards.”

The university is leading or involved in two over-arching projects planned for the region. Arch (A Regional Collaboration for Health) aims to drive forward health research and improve healthcare delivery and also involves two health boards.

Read More

The other is the City Deal for the Swansea Bay City Region , which has a focus on healthcare among other priorities to improve the economy of Swansea, Neath Port Talbot, Carmarthenshire and Pembrokeshire.

Professor Marc Clement, dean of Swansea University’s school of management and a key figure in Arch and the City Deal bid, said: “We are delighted to announce and begin this exciting journey with Pfizer — the latest prestigious international partner with a desire to collaborate with us, following the opening of global technology leader Fujitsu’s new education innovation hub in October 2016.

“Attracting such established, innovative international companies to partner with us in this way is a sign of confidence in our ambition and plans for future growth and expansion. We look forward to the positive outcomes we are confident this new partnership will bring.”

Welsh Government Cabinet Secretary for Health, Wellbeing and Sport, Vaughan Gething, said: “This collaboration has great potential to bring real benefits to patients in Wales.”





Leave a Reply